Aymeric Sallin
Investing Profile
About Aymeric Sallin
We are a venture capital firm focusing on innovative technological advancements.
NanoDimension thesis
× Aymeric Sallin Founder & Chief Executive Officer as@nd.capital Aymeric founded +ND Capital in 2002. He discovered the nanotechnology world while conducting research between the Physics and Chemistry departments of EPFL in the 90’s. He was convinced that significant breakthroughs would arise at the nanoscale and extensive expertise would be required to differentiate science from science fiction. This was the foundation of +ND Capital. Following the raise of the first ND partnership, Aymeric realized that despite great science in Europe, the US was offering better investment opportunities. As
Sector and stage focus
- Series B: AI, BioTech, Health & Hospital Services, Digital Health, Therapeutics, Health IT
- Seed: BioTech, AI, Therapeutics, Health IT, Digital Health, Health & Hospital Services
- Series A: Health IT, BioTech, AI, Health & Hospital Services, Therapeutics, Digital Health
- general: San Francisco Bay Area
- Pre-seed: Health IT, Digital Health, BioTech, Health & Hospital Services, AI, Therapeutics
Is Aymeric Sallin a fit for your round?
Upload your pitch deck and see whether Aymeric Sallin appears in your top 20 matches.
Find investors for your deck